Schioppo, T. et al. 2019. Health-related quality of life burden in scleroderma patients treated with two different intravenous iloprost regimens. Reumatismo. 71, 2 (Jul. 2019), 62–67. DOI:https://doi.org/10.4081/reumatismo.2019.1190.